Results 221 to 230 of about 187,398 (301)

Implementation of Guideline-Directed medical therapy and factors in heart failure with reduced ejection fraction. [PDF]

BMC Cardiovasc Disord
Bekele FW, Alemu WA, Tolla KS, Jada AU, Tekle MA, Adem MK, Yesuf HA.   +6 more
europepmc   +1 more source

Health-related quality of life and six-month hospitalization in older outpatients with heart failure with reduced ejection fraction: a prospective observational study. [PDF]

Health Qual Life Outcomes
Nguyen HT, Nguyen HTM, Nguyen HQ.
europepmc   +1 more source

New Biomarker in Heart Failure With Reduced Ejection Fraction

Circulation Journal, 2014
openaire   +3 more sources

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile. [PDF]

Am J Cardiovasc Drugs
Dandamudi M, Ho VQT, Samaniego-Laguna MA, Arrighini GS, Chamay S, Walia H, Giorgi JM, Barbagelata A.   +7 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Blood Urea/Creatinine Ratio and Mortality in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction. [PDF]

Diseases
Oswald AS, Hussain MS, Roshan MHK, Pigazzani F, Choy AM, Khan F, Mordi IR, Lang CC.   +7 more
europepmc   +1 more source

Clinical and Echocardiographic Profile of Patients With Heart Failure With Reduced Ejection Fraction: A Retrospective Outcome Analysis. [PDF]

Cureus
Irfan S, Padmakaran V, Prasanth R, Nazar S, Srinivas S, Tv AK, Bhandary VS, Patel PV, Baldota R, Puthenveedu Soman A, Vattapothy BA.   +10 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source